Sciact
  • EN
  • RU

Comparison of the therapeutic potential of bacteriophage KpV74 and phage-derived depolymerase (β-glucosidase) against Klebsiella pneumoniae capsular type K2 Научная публикация

Журнал Virus Research
ISSN: 1872-7492 , E-ISSN: 0168-1702
Вых. Данные Год: 2022, Том: 322, Номер статьи : 198951, Страниц : DOI: 10.1016/j.virusres.2022.198951
Авторы Volozhantsev Nikolay V. 1 , Borzilov Alexander I. 1 , Shpirt Anna M. 2 , Krasilnikova Valentina M. 1 , Verevkin Vladimir V. 1 , Denisenko Egor A. 1 , Kombarova Tatyana I. 1 , Shashkov Alexander S. 2 , Knirel Yuriy A. 2 , Dyatlov Ivan A. 1
Организации
1 State Research Center for Applied Microbiology and Biotechnology, 142279 Obolensk, City District Serpukhov, Moscow Region, Russia
2 N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 119991 Moscow, Russia

Реферат: Bacteriophages and phage polysaccharide-degrading enzymes (depolymerases) are garnering attention as possible alternatives to antibiotics. Here, we describe the antimicrobial properties of bacteriophage KpV74 and phage depolymerase Dep_kpv74 specific to the hypervirulent Klebsiella pneumoniae of the K2 capsular type. The depolymerase Dep_kpv74 was identified as a specific glucosidase that cleaved the K2 type capsular polysaccharides of the K. pneumoniae by a hydrolytic mechanism. This depolymerase was effective against thigh soft tissue K. pneumoniae infection in mice without inducing adverse behavioral effects or toxicity. The depolymerase efficiency was similar to or greater than the bacteriophage efficiency. The phage KpV74 had a therapeutic effect only for treating the infection caused by the phage-propagating K. pneumoniae strain and was completely inactive against the infection caused by the K. pneumoniae strain that did not support phage multiplication. The depolymerase was effective in both cases. A mutant resistant to phage and depolymerase was isolated during the treatment of mice with bacteriophage. A confirmed one-base deletion in the flippase-coding wzx gene of this mutant is assumed to affect the polysaccharide capsule, abolishing the KpV74 phage adsorption and reducing the K. pneumoniae virulence.
Библиографическая ссылка: Volozhantsev N.V. , Borzilov A.I. , Shpirt A.M. , Krasilnikova V. , Verevkin V.V. , Denisenko E.A. , Kombarova T. , Shashkov A.S. , Knirel Y.A. , Dyatlov I.A.
Comparison of the therapeutic potential of bacteriophage KpV74 and phage-derived depolymerase (β-glucosidase) against Klebsiella pneumoniae capsular type K2
Virus Research. 2022. V.322. 198951 . DOI: 10.1016/j.virusres.2022.198951 WOS Scopus OpenAlex
Идентификаторы БД:
Web of science: WOS:000871108300002
Scopus: 2-s2.0-85139275764
OpenAlex: W4298112014
Цитирование в БД:
БД Цитирований
OpenAlex 34
Scopus 33
Web of science 31
Альметрики: